Noravax, a clinical stage biotech focusedon vaccines for infectious diseases, announced the appointment of John Trizzino as SVP, international andgovernment alliances. Trizzino, previously vice president of MedImmune’svaccine franchise, will report directly to Noravax president and CEO RahulSinghvi.


Media agencyCMI announced three promotions: Lauren Santangelo and Jana Truax were both promoted from assistantmedia planner I to media planner I, and BrettMarvel was promoted from media planner I to media planner II.